Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Sysmex Corporation
  6. Summary
    6869   JP3351100007

SYSMEX CORPORATION

(6869)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
07/15/2021 07/16/2021 07/19/2021 07/20/2021 07/21/2021 Date
13090 12845 12880 12945 13055 Last
227700 373800 329200 268400 369900 Volume
-2.64% -1.87% +0.27% +0.50% +0.85% Change
Estimated financial data (e)
Sales 2022 343 B 3 102 M 3 102 M
Net income 2022 41 692 M 377 M 377 M
Net cash position 2022 65 343 M 591 M 591 M
P/E ratio 2022 65,5x
Yield 2022 0,58%
Sales 2023 376 B 3 397 M 3 397 M
Net income 2023 49 059 M 444 M 444 M
Net cash position 2023 84 934 M 768 M 768 M
P/E ratio 2023 55,6x
Yield 2023 0,62%
Capitalization 2 729 B 24 686 M 24 678 M
EV / Sales 2022 7,77x
EV / Sales 2023 7,04x
Nbr of Employees 8 445
Free-Float 73,0%
More Financials
Company
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its... 
More about the company
Ratings of Sysmex Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about SYSMEX CORPORATION
07/01QIAGEN N : Allies with Sysmex for Development, Commercialization of Cancer Compa..
MT
07/01QIAGEN Forms Strategic Alliance with Sysmex Corporation for Global Cancer Com..
CI
06/08Th2 Chemokine TARC Kit 'HISCL TARC Assay Kit' is Approved for an Additional I..
AQ
06/02Sysmex America Adds FDA-Cleared XN-10 Blood Bank Mode to Hematology Solutions..
CI
06/02Japan shares rally as reopening hopes boosts travel, real estate firms
RE
06/01Japan shares rally as reopening hopes boosts travel, real estate firms
RE
05/19ThinkCyte, Inc. announced that it has received ¥2.85 billion in funding from ..
CI
05/13Nikkei slumps to 4-month low as inflation scare hits expensive shares
RE
05/12Sysmex Corporation and ThinkCyte, Inc. Agree on Joint Development and Capital..
CI
05/11ThinkCyte, Inc. announced that it expects to receive funding from Sysmex Corp..
CI
04/23SYSMEX : Yaskawa's AutoSorter XN Provides Pre- and Post-Analytic Specimen Proces..
AQ
03/30SYSMEX CORPORATION : Ex-dividend day for final dividend
FA
03/10Japanese shares gain on cyclicals boost, selling in some heavyweights weighs
RE
01/25Roche Holding AG Renews Partnership with Sysmex to Deliver Haematology Testin..
CI
01/04Nikkei slips on virus restrictions, caution before U.S. Senate runoffs
RE
More news
News in other languages on SYSMEX CORPORATION
07/01Qiagen und Sysmex wollen Begleitdiagnostika für Krebserkrankungen anbieten
01/25Bourse Zurich: les indices en montagnes russes pour la 1ère séance de la sema..
01/25DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 25.01.2021 - 15.15 Uhr
01/25Bourse Zurich: gains renforcés, le SMI sous les 11'000 points
01/25ROCHE : résultats d'essais prometteurs pour un traitement en ophtalmologie
More news
Chart SYSMEX CORPORATION
Duration : Period :
Sysmex Corporation Technical Analysis Chart | 6869 | JP3351100007 | MarketScreener
Technical analysis trends SYSMEX CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 13 055,00 JPY
Average target price 12 281,82 JPY
Spread / Average Target -5,92%
EPS Revisions
Managers and Directors
Hisashi Ietsugu Chairman, Chief Executive Officer & President
Yukio Nakajima CFO, Director & Senior Managing Executive Officer
Kaoru Asano Director, CTO & COO-LS Business Unit
Yasuhiro Takachi Manager-Informatics
Tomoo Aramaki GM-Corporate Administration & Manager-Accounting
Sector and Competitors
1st jan.Capi. (M$)
SYSMEX CORPORATION5.28%23 738
ABBOTT LABORATORIES10.33%200 283
MEDTRONIC PLC9.73%168 081
BECTON, DICKINSON AND COMPANY0.34%70 145
HOYA CORPORATION3.33%50 251
ALIGN TECHNOLOGY, INC.19.44%48 667